Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-08

Clinical Trial Update: Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy [Phase 4]

View source ↗

Summary

This clinical trial update reports results from a Phase 4 study comparing sodium bicarbonate to normal saline for preventing contrast-induced nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Normal Saline (0.9% Sodium Chloride) (sodium chloride)
  • Sodium Bicarbonate (sodium bicarbonate)

Snippet

Sponsor: Ospedale Misericordia e Dolce | Conditions: Contrast-Induced Nephropathy | Phase 4 | Status: COMPLETED